USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
TANSNA THERAPEUTICS, INC.
Address:
36 DENBIGH DR
IOWA CITY, IA 52246-4908
Phone:
N/A
URL:
N/A
EIN:
127360029
DUNS:
965017465
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $181,299.00 1

Award List:

Design and synthesis of novel anticonvulsant molecules.

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$181,299.00
Agency:
HHS
Principal Investigator:
Rajesh K. Mishra – 319-335-7516
Abstract:
DESCRIPTION (provided by applicant): In approximately 30% of epileptic patients, seizures are not controlled by currently available therapeutic agents. Even though a number of new chemical entities have entered the marketplace, therapy resistant seizures remain. This project is innovative in that… More